Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Review reveals shorter OS, RFS in young colorectal cancer patients

Publish date:: March 3, 2020

Key clinical point: Young colorectal cancer patients have inferior survival rates compared with their older counterparts.

Major finding: The 3-year overall survival rate was 42% in patients aged 10-25 years and 90% in patients older than 25 years (P less than .0001). The 3-year relapse-free survival rates were 32% and 78%, respectively (P less than .0001).

Study details: A retrospective review of 94 patients aged 10-25 years and 765 patients older than 25 years of age.

Disclosures: The authors reported having no disclosures.

Citation:

Hayes-Jordan A et al. J Am Coll Surg. 2020 Feb 21. doi: 10.1016/j.jamcollsurg.2019.12.043.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Gastroenterology

Younger adults present with more advanced esophageal adenocarcinoma,

DOACs look safe in elective endoscopic procedures,

Upper GI bleeds in COVID-19 not related to increased mortality,

Cryoballoon, cryospray found equivalent for eradicating Barret’s esophagus,